Research presented at ECCMID has highlighted large variations in mortality rate associated with different bloodstream infections, as well as the threat posed by these infections.
Find out more about the headlines from the Conference on Retroviruses and Opportunistic Infections 2019 (CROI) in our round-up of conference news.
In line with World AIDS Day this year we spoke to Andy Ustianowski (North Manchester General Hospital, UK) about the new challenges facing people living with HIV, including aging healthily and happily.
Financial modelling has been used to estimate the costs and likelihood of candidate medicines, vaccines, diagnostics and technologies launching, revealing gaps in the pipeline and in funding.
Clinical trial data has proved a novel, short therapy more effective and safe for the treatment of latent tuberculosis than the standard therapy in both adults and children.
The Joint Committee on Vaccination and Immunisation has stated that a gender-neutral vaccine program would be cost effective in the UK and would protect boys against HPV infection and associated diseases.
Following a study that shed new light on the psychiatric and neurological problems suffered by Ebola survivors, researchers are calling for more specialist support for this population.
In this interview Sally, a Senior Research Fellow at Imperial College London’s Faculty of Medicine (London, UK), speaks about her work on issues relating to the vaccination and screening of migrants, in addition to discussing some of the wider issues facing migrant’s access to healthcare in Europe.
This month has seen us focus on travel and migration – a theme of increasing importance in the modern-day world. In light of this we caught up with Marta Tilli on her research investigating the burden of infectious diseases in the Moria refugee camp (Levos, Greece).
A study presented at ECCMID has suggested patient outcomes for Gram-negative bacteremia are similar in the case of 7 days and 14 days of antibiotic treatment, suggesting a shorter course length could be beneficial.
